// App-Quantinova.ai

3117 : Pleiotrophin is a marker of poor prognosis in Middle Eastern papillary thyroid carcinoma

Researchers

Presenter

  • Shaham Beg

Principal Investigators

  • Maqbool Ahmed

  • Azhar Hussein

  • Rong Bu

  • Zeeshan Qadri

  • Saif AlSobhi

  • Fouad Al Dayel

  • Abdul K. Siraj

  • Khawla S. Al-Kuraya

Medical Centers

  • King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi Arabia

Locations

  • Saudi Arabia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Papillary carcinoma

  • Thyroid Cancer

  • Solid malignancies

Biomarkers

  • Midkine

  • Patched 1

  • Cluster of differentiation 45

  • Pleiotrophin

Drug/Treatment

  • L-Tyrosine

  • Heparin

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved